Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
XTNT Xtant Medical Holdings Inc
- Stocks
- Healthcare
- NYSEAMERICAN: XTNT
Price (delayed)
$0.64
Market cap
$89.17M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.09
Enterprise value
$118.03M
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal
Highlights
XTNT's net income is up by 27% since the previous quarter
The company's EPS rose by 25% QoQ
XTNT's debt is up by 19% year-on-year but it is down by 2.4% since the previous quarter
The equity has contracted by 8% YoY but it has grown by 2.1% from the previous quarter
Xtant Medical Holdings's gross margin has decreased by 5% YoY
Key stats
What are the main financial stats of XTNT
Market
Valuations
Earnings
Shares outstanding
139.32M
Market cap
$89.17M
Enterprise value
$118.03M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.03
Price to sales (P/S)
0.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.97
Revenue
$122.3M
Gross profit
$71.16M
Operating income
-$7.54M
Net income
-$11.99M
EBIT
-$7.53M
EBITDA
-$3.24M
Free cash flow
-$9.06M
Per share
Balance sheet
Liquidity
EPS
-$0.09
EPS diluted
-$0.09
Free cash flow per share
-$0.07
Book value per share
$0.32
Revenue per share
$0.88
TBVPS
$0.58
Total assets
$95.83M
Total liabilities
$51.96M
Debt
$34.3M
Equity
$43.88M
Working capital
$39.56M
Debt to equity
0.78
Current ratio
2.34
Quick ratio
0.98
Net debt/EBITDA
-8.92
Margins
Efficiency
Dividend
EBITDA margin
-2.6%
Gross margin
58.2%
Net margin
-9.8%
Operating margin
-6.2%
Return on assets
-12.5%
Return on equity
-27%
Return on invested capital
-9.5%
Return on capital employed
-11.4%
Return on sales
-6.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
XTNT stock price
How has the Xtant Medical Holdings stock price performed over time
Intraday
-4.48%
1 week
-10.49%
1 month
-7.91%
1 year
-3.03%
YTD
44.47%
QTD
-13.4%
Financial performance
How have Xtant Medical Holdings's revenue and profit performed over time
Revenue
$122.3M
Gross profit
$71.16M
Operating income
-$7.54M
Net income
-$11.99M
Gross margin
58.2%
Net margin
-9.8%
Xtant Medical Holdings's operating margin has increased by 48% YoY and by 40% from the previous quarter
XTNT's operating income is up by 38% since the previous quarter and by 37% year-on-year
XTNT's net margin is up by 30% since the previous quarter
XTNT's net income is up by 27% since the previous quarter
Price vs fundamentals
How does XTNT's price correlate with its fundamentals
Growth
What is Xtant Medical Holdings's growth rate over time
Valuation
What is Xtant Medical Holdings stock price valuation
P/E
N/A
P/B
2.03
P/S
0.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.97
The company's EPS rose by 25% QoQ
XTNT's P/B is 25% below its 5-year quarterly average of 2.7 but 19% above its last 4 quarters average of 1.7
The equity has contracted by 8% YoY but it has grown by 2.1% from the previous quarter
The stock's price to sales (P/S) is 44% less than its 5-year quarterly average of 1.3 but 22% more than its last 4 quarters average of 0.6
The revenue is up by 21% year-on-year and by 4.3% since the previous quarter
Efficiency
How efficient is Xtant Medical Holdings business performance
The company's return on sales rose by 40% QoQ
Xtant Medical Holdings's ROIC has increased by 39% from the previous quarter
Xtant Medical Holdings's ROA has increased by 27% from the previous quarter
The ROE has grown by 26% from the previous quarter
Dividends
What is XTNT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for XTNT.
Financial health
How did Xtant Medical Holdings financials performed over time
The total assets is 84% more than the total liabilities
Xtant Medical Holdings's total liabilities has increased by 12% YoY and by 2.1% from the previous quarter
Xtant Medical Holdings's quick ratio has increased by 7% YoY and by 4.3% from the previous quarter
XTNT's debt is 22% smaller than its equity
The debt to equity has increased by 30% YoY but it has decreased by 4.9% from the previous quarter
XTNT's debt is up by 19% year-on-year but it is down by 2.4% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.